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Genistein inhibits CCAAT/enhancer-binding protein β (C/EBPβ) activity and
3T3-L1 adipogenesis by increasing C/EBP homologous protein expression
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The tyrosine kinase inhibitor genistein inhibits 3T3-L1
adipogenesis when present during the first 72 h of differentiation.
In this report, we investigated the underlying mechanisms
involved in the anti-adipogenic effects of genistein. We found that
genistein blocked the DNA binding and transcriptional activity
of CCAAT}enhancer-binding protein β (C}EBPβ) during
differentiation by promoting the expression of C}EBP hom-
ologous protein, a dominant-negative member of the C}EBP
family. Loss of C}EBPβ activity was manifested as a loss of
differentiation-induced C}EBPα and peroxisome-proliferator-
activated receptor γ protein expression and a dramatic reduction
INTRODUCTION
In white adipose tissue, preadipocytes exist in close proximity to
adipocytes and respond to positive energy balance by pro-
liferating and then differentiating into adipocytes [1,2]. Mature
adipocytes then accommodate excess energy through enhanced
triacylglycerol storage. Many of the advances in our under-
standing of adipogenesis are based on studies in murine 3T3-L1
cells [3]. As preadipocytes, 3T3-L1 cells resemble fibroblasts.
They replicate in culture until they form a confluent monolayer,





apparent prerequisite for subsequent differentiation into adipo-
cytes [4]. Stimulation with 1-methyl-3-isobutylxanthine (MIX),
dexamethasone and high doses of insulin in serum-containing
medium (MDI protocol) for 2–3 days prompts these cells to
undergo postconfluent mitotic clonal expansion, exit the cell
cycle and commit to terminal differentiation (reviewed in [5]).
Adipogenesis involves co-operative interaction between
members of the CCAAT}enhancer-binding protein (C}EBP)
and peroxisome-proliferator-activated receptor (PPAR) families,
the primary adipogenic transcription factors. C}EBPβ, expressed
immediately after the induction of differentiation, acquires
DNA-binding capacity by 12–16 h [6] and dominates in inducing
the initial expression of both PPARγ and C}EBPα on days 2 and
3 of differentiation. PPARγ and C}EBPα then induce the
expression of each other and act synergistically to promote
adipogenesis by transactivating the promoters of several
adipocyte-specific genes [7,8].
Adipogenesis also requires the down-regulation of repressive
factors, such as preadipocyte factor-1 [9], Wnts [10] and
GATA factors [11], which maintain preadipocytes in the un-
differentiated state. Several members of the C}EBP family also
function as repressors of differentiation by forming inactive
heterodimers with C}EBPβ and C}EBPα. C}EBP homologous
Abbreviations used: ALLN, N-acetyl-Leu-Leu-norleucinal ; C/EBP, CCAAT/enhancer-binding protein ; CHOP, C/EBP homologous protein ; DMEM,
Dulbecco’s modified Eagle’s medium; DTT, dithiothreitol ; EGF, epidermal growth factor ; FBS, foetal bovine serum; GADD153, growth arrest and DNA
damage-inducible gene 153; MIX, 1-methyl-3-isobutylxanthine ; MDI, MIX, dexamethasone and insulin ; NP40, Nonidet P40; PPAR, peroxisome-
proliferator-activated receptor.
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in lipid accumulation. Further, we documented for the first time
that C}EBPβ was tyrosine-phosphorylated in io during
differentiation and in itro by activated epidermal growth factor
receptor. Genistein inhibited both of these events. Collectively,
these results indicate that genistein blocks adipogenesis and
C}EBPβ activity by increasing the level of C}EBP homologous
protein and possibly by inhibiting the tyrosine phosphorylation
of C}EBPβ.
Key words: adipocyte, daidzein, peroxisome-proliferator-
activated receptor γ (PPARγ), preadipocyte.
protein [CHOP; also known as growth arrest and DNA damage-
inducible gene 153 (GADD153)] functions as a dominant-
negative inhibitor of the DNA-binding activity of C}EBPβ and
C}EBPα [12]. Similarly, heterodimers containing C}EBPβ
and either C}EBPγ or liver inhibitory protein, the truncated
isoform of C}EBPβ, attenuate the transcriptional activity of
C}EBPβ (reviewed in [13]). C}EBPα undifferentiated protein
differs from the repressive C}EBPs in that it is expressed only by
preadipocytes and it blocks transactivation of the C}EBPα gene
promoter not by forming an inactive heterodimer but by oc-
cluding the binding site of a transcriptional activator [14].
Since the discovery in 1987 that genistein functions as a
tyrosine kinase inhibitor [15], authors of more than 2500 pub-
lished papers have used genistein to gauge tyrosine kinase activity
in numerous cell lines. Wang and Malbon [16] have reported that
genistein blocks 3T3-L1 cell differentiation in a dose-dependent
manner. We [17] have found that genistein inhibits the pro-
liferation of preconfluent preadipocytes, as well as the mitotic
clonal expansion of postconfluent preadipocytes and their sub-
sequent differentiation into adipocytes. However, when added
on day 3 of differentiation, genistein has no inhibitory effect on
adipogenesis. Given that the timing of genistein’s anti-adipogenic
effect coincides with the expression of C}EBPβ, C}EBPα and
PPARγ, we hypothesized that genistein inhibits 3T3-L1 cell
differentiation by preventing key tyrosine phosphorylation events
involved in the expression or activation of these adipogenic
transcription factors.
We report here that genistein increased CHOP expression,
blocked the DNAbinding and transcriptional activity of C}EBPβ
and prevented the subsequent expression of C}EBPα and
PPARγ. Because daidzein, which is structurally similar to
genistein but inactive as a tyrosine kinase inhibitor, had no
adverse effect on adipogenesis, we examined whether a tyrosine
phosphorylation event regulates C}EBPβ activity. We found, for
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the first time, that both MDI and activated epidermal growth
factor (EGF) receptor induced the tyrosine phosphorylation of
C}EBPβ and that genistein inhibited these events.
MATERIALS AND METHODS
Materials
All tissue culture materials were from Gibco (Grand Island, NY,
U.S.A.). Genistein (4«,5,7-trihydroxyisoflavone), daidzein (4«,7-
dihydroxyisoflavone) and activated EGF receptor tyrosine kinase
were from Calbiochem (San Diego, CA, U.S.A.). Insulin, dexa-
methasone and MIX were from Sigma. Protein A}G–agarose,
GADD153 fusion protein, anti-C}EBPα (14AA), anti-C}EBPβ
(H-7), anti-GADD153 (B-3) and anti-PPARγ (E-8) antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
Anti-phosphotyrosine (PY20) antibody was from PharMingen-
Transduction Laboratories (Lexington, KY, U.S.A.). Anti-
phosphotyrosine (4G10) antibody was from Upstate Bio-
technology (Lake Placid, NY, U.S.A.). The enhanced chemi-
luminescence (ECL) detection kit, horseradish peroxidase conju-
gated secondary antibodies and [γ-$#P]ATPwere from Amersham
Pharmacia Biotech (Piscataway, NJ, U.S.A.). Luciferase assay
reagents were from BD Pharmingen (San Diego, CA, U.S.A.).
Cell culture
3T3-L1 preadipocytes (A.T.C.C., Manassas, VA, U.S.A.) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) with
10% (v}v) foetal bovine serum (FBS), 1% (v}v) penicillin–
streptomycin (10000 units}ml penicillin, 10000 µg}ml strepto-
mycin in 0.85% saline) and 1% (v}v) 100 µM pyruvate at 37 °C
in 95% air, 5% CO
#
. To induce differentiation, 2-day post-
confluent 3T3-L1 preadipocytes (day 0) were stimulated for 72 h
with 0.5 mM MIX, 0.5 µM dexamethasone and 10 µg}ml insulin
(MDI) added to DMEM}10% FBS culture medium. On day 3,
the MDI medium was replaced with DMEM}10% FBS, which
was changed every 2 days thereafter until analysis. Isoflavones
were reconstituted as 100 mM stock solutions in DMSO, filter-
sterilized and stored at ®20 °C. For each experiment, cells
received isoflavones diluted in MDI differentiation medium.
Oil Red O staining
3T3-L1 adipocytes were washed with PBS (5% sucrose), fixed
with 10% glutaraldehyde in PBS (pH 7.4), and stained with
0.5% Oil Red O.
Preparation of whole-cell lysates





, and then placed immediately in SDS-lysis buffer [1%
Nonidet P40 (NP40), 20 mM Tris}HCl (pH 8.0), 150 mM NaCl,
1 mM EDTA, 0.1% NaN
$
, 10 µg}ml aprotinin, 1 µM pepstatin,





10% glycerol] without dithiothreitol (DTT) or tracking dye.
Samples were heated for 10 min at 95 °C before protein concen-
trations were determined using the Bio-Rad DC protein de-
termination kit.
Preparation of nuclear extracts
3T3-L1 cells were washed twice in PBS, once in hypotonic lysis
buffer (20 mM Tris}HCl, 10 mM NaCl and 3 mM MgCl
#
), and
then scraped in hypotonic lysis buffer containing 1 mM
DTT, 2 µl}ml Pic I (1 mg}ml leupeptin, 1 mg}ml antipain
10 mg}ml benzamidine and 1 mg}ml aprotinin) and 2 µl}ml Pic
II (1 mg}ml chymostatin, 1 mg}ml pepstatin A in DMSO). A
1:100 volume of 10% NP40 was added, and cells were lysed
by Dounce homogenization. After centrifugation for 5 min at
2200 rev.}min (4 °C), the supernatant was discarded and the
crude nuclear pellet was washed in hypotonic lysis buffer
containing protease inhibitors, resuspended in nuclear storage
buffer [40% glycerol, 50 mM Tris (pH 8.8), 3 mM MgCl
#
, 1 mM
DTT, 2 µl}ml Pic I, 2 µl}ml Pic II], and transferred to a micro-
centrifuge tube. Pelleted nuclei were then resuspended in 10¬
volume of NUN buffer [1.1 M urea, 0.33 M NaCl, 17.5 mM
Hepes (pH 7.6), 1.1 mM DTT, 2 µl, ml Pic I, 2 µl}ml Pic II],
vortex-mixed for 5 s, incubated on ice for 30 min and centrifuged
for 10 min at 14000 rev.}min (4 °C) in a microcentrifuge. The
supernatant was transferred to a fresh microcentrifuge tube and
glycerol was added (10% final volume). Samples were diluted 10
times in water before protein concentrations were determined,
using theBio-RadDC protein determination kit. Nuclear extracts
were stored at ®80 °C. Nuclear extracts obtained by this method
contain no cytoplasmic proteins, as confirmed by the absence
of heat-shock protein-90 [18] by immunoblot analysis using
anti-heat-shock protein-90 (Transduction Laboratories) (results
not shown).
Immunoblot analysis
Before adding 100 mM DTT and tracking dye, protein concen-
trations of whole-cell lysates or nuclear extracts were determined
using the Bio-Rad DC protein determination kit. BSA was used
as the standard. Samples were heated for 5 min at 95 °C,
separated by SDS}PAGE (10% gel), and analysed by immuno-
blotting as described previously [19,20]. Immunoblots were
developed with the ECL2 kit.
Immunoprecipitation
Cells were placed in ice-cold gentle-lysis buffer [25 mM Tris}HCl









, 1 mM PMSF,
10 µg}ml aprotinin] and rocked on ice for 30 min. The lysed cells
were harvested and centrifuged at 6000 g for 20 min at 4 °C.
Supernatants were removed and protein concentrations were
determined. For immunoprecipitations, PY20 antibody
(10 µg}ml) was added to lysates, which contained equal amounts
of protein (700 µg) ; incubation occurred overnight at 4 °C.
Protein A}G–agarose beads were mixed with the immuno-
precipitates on a rocker for 1 h at 4 °C. Immunoprecipitates were
recovered by centrifugation at 2500 g and washed three times
with ice-cold gentle-lysis buffer containing protease inhibitors.
Immunoprecipitated proteins were dissolved in 2¬ sample buffer
and analysed by SDS}PAGE as described above.
Plasmids and transfection
Two-day postconfluent (d 0) 3T3-L1 preadipocytes were tran-
siently co-transfected with calcium phosphate-precipitated DNA
containing 5 µg of a C}EBPα promoter-luciferase construct [21]
and 5 µg of a C}EBPβ expression vector [22] provided by M.
Daniel Lane (Johns Hopkins University School of Medicine).
Four hours after transfection, cells were glycerol-shocked (12.5%
glycerol in 1¬PBS, filter-sterilized) for 2 min and then placed in
MDI differentiation medium plus 0.1% DMSO vehicle or
100 µM genistein. After 48 h, cells were washed once with PBS,
scraped in lysis buffer containing 100 mM KPO
%
(pH 7.8), 1%
Triton X-100, 1 mM DTT and 2 mM EDTA, and stored at
®20 °C until analysis for luciferase activity (Enhanced Luciferase
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Assay Kit ; PharMingen), which was normalized to that of
undifferentiated day 0 cells (transfection but no MDI stimu-
lation).
Electrophoretic mobility-shift assay
Nuclear extracts from 3T3-L1 cells induced to differentiate for
36 h in the presence of vehicle or 100 µM genistein were prepared
as outlined above and stored at ®80 °C. Protein concentrations
were determined using the Bio-Rad DC protein determination
kit. A [γ-$#P]ATP-labelled (Amersham) double-stranded oligo-
nucleotide probe (20 bp) corresponding to the C}EBP binding
site in the C}EBPα promoter (GCG TTG CGC CAC GAT CTC
TC, nt 191–172 [23]) was used for gel shift assays. The binding
reaction mixture contained approx. 100000 c.p.m. of labelled
DNA, 2 µg of poly(dI}dC) and 10 µg of cell extract protein in
30 µl of buffer (10 mM Hepes}0.1 mM EDTA}5% glycerol}
100 mM NaCl}0.3 M urea}0.3% NP40); this mixture was
incubated on ice for 30 min. Where indicated, 0.4 µg of anti-C}
EBPβ antibody (Santa Cruz) was added to the binding
reaction. The reactions were analysed by 5% PAGE in
0.5¬Tris}borate}EDTA buffer, followed by autoradiography.
In vitro kinase assay
Protein lysates from 3T3-L1 cells differentiated for 0 or 24 h were
subjected to immunoprecipitation as described above using 3 µg
of C}EBPβ antibody}ml of lysate, containing 1 mg of protein.
Immunoprecipitates were washed three times with NP40 lysis
buffer [1% NP40}20 mM Tris}HCl (pH 8.0)}150 mM NaCl}
1 mM EDTA}0.1% NaN
$
], then twice with KA buffer (50 mM
Hepes (pH 7.6)}0.1 mM EDTA}0.015% Brij 35). Active EGF
receptor kinase in KD buffer [50 mM Hepes (pH 7.6), 0.1 mM
EDTA, 0.015% Brij 35, 0.1 mg}ml BSA, 0.2% 2-
mercaptoethanol] was then added (approx. 1 unit}reaction),
followed by approx. 5 µCi of [γ-$#P]-labelled ATP in ATP buffer
[50 mM Hepes (pH 7.6)}0.1 mM EDTA}0.015% Brij 35}30 mM
MgCl
#
}0.15 mM ATP]. Samples were heated at 30 °C for 30 min.
After the addition of loading dye, samples were heated at 100 °C
for 2 min, separated by SDS}PAGE (10–15% gel), transferred
to a nitrocellulose membrane, and analysed by autoradiography.
Statistical analysis
Data are expressed as means³S.E.M. The significance of
differences between means, set at P! 0.05, was assessed by
Student’s t test (Microsoft Excel). Unless noted otherwise,
reported results were reproduced in two additional independent
experiments.
RESULTS
Genistein inhibits the expression of C/EBPα and PPARγ, but has
no effect on C/EBPβ expression
Previous studies have demonstrated that genistein inhibits 3T3-
L1 adipogenesis [16,17]. To determine whether genistein’s anti-
adipogenic effects result from inhibition of tyrosine kinase
activity, we differentiated 3T3-L1 cells in the presence of genistein
or daidzein. Although the structure of daidzein is nearly identical
with that of genistein, with the exception of one critical hydroxyl
group (Figure 1A), daidzein has no inhibitory effect on tyrosine
kinase activity [15]. As shown in Figure 1(B), genistein dra-
matically inhibited lipid accumulation, compared with the vehicle
control. Daidzein treatment, on the other hand, had little or no
inhibitory effect. To determine the point in the differentiation
Figure 1 Effect of genistein versus daidzein on 3T3-L1 cell differentiation
(A) Structures of genistein and daidzein. (B) Two-day postconfluent 3T3-L1 cells (day 0) were
induced to differentiate for 72 h in the presence of vehicle, 100 µM genistein or 100 µM
daidzein. After 72 h, the differentiation medium was replaced with DMEM/10% FBS. On day
8 after induction of differentiation, cells were stained with Oil Red O.
programme where genistein exerts its anti-adipogenic effects, we
examined the expression pattern of three transcription factors
critical for adipogenesis, C}EBPβ, C}EBPα and PPARγ.
Approximately 4 h after the induction of differentiation, 3T3-L1
Figure 2 Effect of genistein on the expression of adipogenic transcription
factors
Two-day postconfluent 3T3-L1 cells induced to differentiate for 72 h in the presence of vehicle,
100 µM genistein or 100 µM daidzein were lysed on the indicated days for immunoblot
analysis with antibodies against C/EBPβ, C/EBPα and PPARγ, all at a dilution of 1 : 200.
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Figure 3 Effect of genistein on C/EBPβ activity
Two-day postconfluent 3T3-L1 cells were induced to differentiate in the presence of vehicle (V)
or 100 µM genistein (G) and nuclear extracts were prepared, as outlined in the Materials and
methods section. (A) Immunoblot analysis of nuclear extracts shows nuclear translocation of
C/EBPβ 36 h after MDI compared with 0 time (no MDI stimulation) or a control (CT) whole-
cell lysate. (B) Electrophoretic mobility-shift assays were performed using a radiolabelled
oligonucleotide probe corresponding to the C/EBP binding site in the C/EBPα promoter.
Binding reactions were performed in the presence of anti-C/EBPβ where indicated. The same
results were obtained in another independent experiment. (C) To assess transcriptional activity
of C/EBPβ, a luciferase assay was performed, as outlined in the Materials and methods section.
Relative luciferase activity indicates the fold increase over the average light intensity emitted
by transfected but unstimulated control cells. The results reflect the means³S.E.M. for three
independent experiments ; *P ! 0.002, significantly different from vehicle. (D) Lysates obtained
at the indicated times were immunoblotted with anti-C/EBPα antibody. The membrane was
stripped and re-probed with anti-C/EBPβ antibody to show equal protein loading.
cells express C}EBPβ [6]. After a 24–48 h delay, C}EBPβ triggers
the expression of both PPARγ and C}EBPα, which then
promote the expression of each other and a number of adipocyte-
specific genes (reviewed in [7]). As shown in Figure 2, genistein
had no effect on MDI-induced C}EBPβ expression, but dramati-
cally inhibited the expression of both C}EBPα and PPARγ.
As expected, daidzein had no effect on the expression of C}EBPβ,
C}EBPα or PPARγ.
Genistein inhibits C/EBPβ activity
The results in Figure 2 indicate that genistein blocks adipogenesis
downstream of C}EBPβ expression but upstream of C}EBPα
and PPARγ expression. Because the initial expression of both
C}EBPα and PPARγ relies on C}EBPβ activity, we determined
whether C}EBPβ is transcriptionally active in the presence of
genistein. Although genistein had no effect on C}EBPβ trans-
location to the nucleus (Figure 3A), its presence markedly
impaired the ability of C}EBPβ to bind an oligonucleotide
corresponding to the C}EBP site in the C}EBPα promoter
(Figure 3B). Because impaired DNA binding should also impair
transcriptional activity, we examined whether genistein inhibits
C}EBPβ-induced transactivation of C}EBPα. We transiently co-
transfected cells with a C}EBPα promoter-luciferase construct
and a C}EBPβ expression vector, induced differentiation for
48 h in the presence of vehicle or genistein, and analysed the cell
lysates for luciferase activity. Figure 3(C) shows that genistein
inhibited C}EBPβ-induced transactivation of the C}EBPα pro-
moter by approx. 60% compared with the vehicle control.
Figure 3(D) shows a time course of MDI-induced C}EBPβ and
Figure 4 Effect of genistein on CHOP expression
Two-day postconfluent 3T3-L1 cells were induced to differentiate in the presence of vehicle or
100 µM genistein, and day 0–day 2 whole-cell lysates (A) or 36 h nuclear extracts from two
independent experiments (B) were immunoblotted with an antibody against CHOP (GADD153)
(1 : 100). This antibody also recognizes a 57 kDa tagged fusion protein corresponding to amino
acids 1–168 of GADD153, which was included as a positive control (CT). The nuclear extract
membrane was stripped and reprobed with an antibody against C/EBPβ.
C}EBPα expression in the presence of vehicle or genistein. In
both vehicle- and genistein-treated cells, C}EBPβ remained at
high levels throughout day 3 and declined by day 4. Although
C}EBPα expression increased dramatically on day 3 in vehicle-
treated cells, its expression remained low in genistein-treated cells
despite high levels of C}EBPβ.
Genistein increases CHOP expression
The basic DNA-binding region of CHOP contains proline and
glycine substitutions for asparagine, aliphatic and basic residues
that are conserved in other members of the C}EBP family. These
substitutions prevent CHOP–C}EBP heterodimers from binding
a number of C}EBP consensus sites, including adipose-specific
sites [12]. By dimerizing avidly with C}EBPβ and C}EBPα,
CHOP functions as a transcriptional inhibitor of adipogenesis
that blocks the differentiation of 3T3-L1 preadipocytes when
ectopically expressed [24] or when up-regulated by the protease
inhibitor N-acetyl-Leu-Leu-norleucinal (ALLN) [23].
To determine whether inhibition of C}EBPβ DNA binding by
genistein results from increased expression of CHOP, we
differentiated 3T3-L1 preadipocytes for 0–48 h in the presence of
vehicle or genistein and analysed whole-cell lysates (Figure 4A)
and nuclear extracts (Figure 4B) for CHOP expression. Treat-
ment with genistein, but not vehicle, dramatically increased the
level of CHOP.
Genistein inhibits the MDI-induced tyrosine phosphorylation of
C/EBPβ
Although many researchers have demonstrated the importance
of serine and threonine phosphorylation in regulating C}EBPβ
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Figure 5 Effect of genistein on the tyrosine phosphorylation of C/EBPβ
Day 0 cells were differentiated in the presence of vehicle or 100 µM genistein and lysed at
the indicated times for (A) immunoprecipitation (IP) with 10 µg/ml anti-phosphotyrosine
antibody (PY20), followed by immunoblotting (IB) with anti-C/EBPβ antibody. The membrane
was stripped and re-probed with anti-phosphotyrosine antibodies (PY20/4G10, 1 : 1000 each).
The control lane (CT) contains a non-immunoprecipitated whole-cell lysate from cells
differentiated for 24 h. For the in vitro kinase assay (B), protein lysates from day 0
cells differentiated for 24 h in the presence of vehicle or 100 µM genistein were immuno-
precipitated with 3 µg of C/EBPβ antibody/ml of lysate containing 1 mg of protein. Active EGF
receptor kinase and [γ-32P]-labelled ATP were added. Samples were heated, separated by
SDS/PAGE (10–15%), transferred to a nitrocellulose membrane and analysed by auto-
radiography. Membranes containing immunoprecipitated C/EBPβ were stripped and re-probed
with anti-C/EBPβ antibody.
activity (reviewed in [25]), no published studies have reported
that C}EBPβ undergoes tyrosine phosphorylation in response to
MDI stimulation. Because genistein is a tyrosine kinase inhibitor
that blocks adipogenesis and C}EBPβ activity, we examined
whether C}EBPβ undergoes tyrosine phosphorylation during
adipogenesis andwhether genistein inhibits this process. Immuno-
precipitation of tyrosine-phosphorylated proteins from cells
stimulated with MDI plus vehicle or genistein for 2 or 3 days,
followed by immunoblotting with an antibody against C}EBPβ,
showed that MDI induced the tyrosine phosphorylation
of C}EBPβ (both the 34 and 38 kDa isoforms) on day 3 of
differentiation and that genistein inhibited this event (Figure
5A). Stripping and re-probing the membrane with antibodies
against tyrosine-phosphorylated proteins (PY20}4G10) con-
firmed that on day 3 of differentiation, vehicle-treated cells, but
not genistein-treated cells, contained 34 and 38 kDa tyrosine-
phosphorylated proteins.
Although serine and threonine kinases phosphorylate residues
in specific consensus sites, tyrosine kinases are relatively pro-
miscuous [26]. Not knowing the identity of the kinase that
tyrosine phosphorylates C}EBPβ, we speculated that the EGF
receptor, which has intrinsic tyrosine kinase activity [27], would
in itro phosphorylate C}EBPβ. Figure 5(B) shows that genistein
inhibited the tyrosine phosphorylation of C}EBPβ by the active
EGF receptor kinase.
DISCUSSION
In the present study, we demonstrated that genistein disrupts the
adipogenic programme by blocking C}EBPβ activity, which in
turn prevents the expression of both C}EBPα and PPARγ, key
adipogenic transcription factors. Several researchers have es-
tablished that in preadipocyte cell lines, adipogenesis is driven by
the following cascade of transcription factors : C}EBPβ and
C}EBPδ, expressed soon after the induction of differentiation,
synergistically promote the expression of both C}EBPα and
PPARγ, the primary adipogenic transcription factors [28]. In
3T3-L1 cells, disruption of this cascade blocks the differentiation
programme [29]. In addition, primary embryonic fibroblasts
derived from C}EBPβ}δ knockout mice neither differentiate nor
express C}EBPα and PPARγ in response to MDI stimulation
[30]. These results indicate that C}EBPβ and C}EBPδ function
as the primary inducers of C}EBPα and PPARγ in cell culture.
We examined the effect of genistein on C}EBPβ activity, not on
C}EBPδ activity, because, of the two, C}EBPβ functions as the
dominant isoform [29]. We found that genistein had no inhibitory
effect on C}EBPδ expression (results not shown). Additionally,
Figure 3(B) shows that in the presence of genistein, no C}EBP
isoform binds to the C}EBP site, suggesting that genistein
inhibits C}EBPδ activity as well as C}EBPβ activity. Thus
genisteinmay function as the equivalent of aC}EBPβ}δknockout
in terms of the activity of these transcription factors.
We found that genistein impairs the ability of C}EBPβ to bind
to DNA. Importantly, our results showed that genistein increases
the expression of CHOP, a dominant-negative C}EBP isoform
that readily forms heterodimers with C}EBPβ and prevents
C}EBPβ from binding to DNA [12]. Our findings agree with
those of Tang and Lane [23], who demonstrated that ALLN-
induced up-regulation of CHOP during the first 48 h of MDI
stimulation blocks C}EBPβ DNA binding, C}EBPα expression
and subsequent differentiation without affecting C}EBPβ ex-
pression. Although Tang and Lane did not determine how
ALLN induces CHOP expression (or prevents turnover of the
CHOP message), changes in cell cycle proteins may be involved.
For example, ALLN blocks mitotic clonal expansion and
differentiation of 3T3-L1 cells by preventing the turnover of the
cyclin-dependent kinase inhibitor p27 [31]. Genistein also inhibits
mitotic clonal expansion [17] but did not inhibit the MDI-
induced degradation of p27 (results not shown) that normally
occurs on days 1 and 2 of differentiation [31,32]. Thus we
speculate that the anti-adipogenic effects of genistein and ALLN
result from different mechanisms. Further studies are needed to
determine how genistein regulates CHOP expression.
The isoflavone daidzein resembles genistein, but possesses no
activity as a tyrosine kinase inhibitor [15]. The finding that
daidzein had minimal to no adverse effect on adipogenesis
suggests that anti-adipogenic effects of genistein result from the
inhibition of critical tyrosine phosphorylation events. Import-
antly, our reciprocal immunoprecipitation and in itro kinase
studies showed for the first time that C}EBPβ becomes tyrosine-
phosphorylated during differentiation and that genistein blocks
this event. C}EBPβ becomes tyrosine-phosphorylated on day 3
of differentiation, which correlates with the timing of C}EBPβ-
induced C}EBPα expression. Tyrosine phosphorylation, a well-
known mechanism for protein activation [33], may therefore
regulate the transcriptional activity of C}EBPβ. Although our
results showed that C}EBPβ is tyrosine-phosphorylated during
adipogenesis, we cannot rule out the possibility that MDI induces
the tyrosine phosphorylation of other proteins that co-immuno-
precipitate with C}EBPβ. However, it is highly unlikely that the
proteins would have exactly the same molecular masses as
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the C}EBPβ isoforms (34 and 38 kDa) and produce a similar
expression pattern during adipogenesis.
We have not yet identified the tyrosine residues on C}EBPβ
that become phosphorylated during adipogenesis. C}EBPβ has
ten tyrosine residues, seven of which are located in the N-
terminal transactivation domain. C}EBPβ also has 20 serine
residues located throughout the protein. In a previous study [25],
several of these serines were identified as sites of regulation
via phosphorylation, but no one has suggested a role for tyrosine
phosphorylation in the regulation of C}EBPβ activity. Extensive
mutagenesis studies will be necessary to identify the regulatory
tyrosines on C}EBPβ and the specific combinations of phospho-
serines and phosphotyrosines required for optimal activity of this
transcription factor.
Genistein has proven to be a useful tool for advancing our
understanding of cell signalling in the field of adipogenesis. By
identifying CHOP and C}EBPβ as targets of genistein, however,
we have raised the possibility that pharmacological levels of
genistein, currently under investigation as a treatment for breast
and prostate cancer [34], may produce unwanted effects in
several other tissues. For example, liver, lung and intestine,
which also express high levels of C}EBPβ, rely on this trans-
cription factor for normal cell growth and differentiation [35].
Animal and human studies should therefore be conducted to
determine the effects of genistein on liver, lung, intestine and
adipose tissue.
This work was supported by the U.S. Public Health Service grant DK53398, the
University Research Council and the Institute of Nutrition at the University of North
Carolina.
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